GAMMA Investing’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$886K Buy
12,226
+3,457
+39% +$249K 0.03% 470
2026
Q2
$620K Sell
8,769
-1,296
-13% -$70K 0.02% 558
2026
Q1
$526K Buy
10,065
+3,294
+49% +$198K 0.02% 553
2025
Q4
$398K Buy
6,771
+1,456
+27% +$88.5K 0.02% 623
2025
Q3
$296K Buy
5,315
+2,720
+105% +$146K 0.02% 727
2025
Q2
$134K Buy
2,595
+800
+45% +$40.2K 0.01% 1212
2025
Q1
$105K Sell
1,795
-1,101
-38% -$74.6K 0.01% 1209
2024
Q4
$209K Buy
2,896
+333
+13% +$24.5K 0.02% 668
2024
Q3
$205K Buy
2,563
+591
+30% +$44.4K 0.02% 615
2024
Q2
$141K Buy
1,972
+879
+80% +$64.7K 0.02% 614
2024
Q1
$76.9K Buy
1,093
+463
+73% +$33.1K 0.02% 769
2023
Q4
$44.3K Buy
+630
New +$41.5K 0.01% 962

Other funds holding TECH

GAMMA Investing's TECH Position: Q3 2026 in Review

GAMMA Investing increased its Bio-Techne (TECH) stake by 39% in Q3 2026, buying an estimated $249K and bringing the position to 12,226 shares worth $886K. The position accounts for 0.03% of the portfolio, ranked #470.

GAMMA Investing first reported a position in TECH in Q4 2023 and has held it in 12 quarters since. 15 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • GAMMA Investing held 12,226 shares of Bio-Techne worth $886K as of Q3 2026.
  • GAMMA Investing bought 3,457 Bio-Techne shares in Q3 2026, an estimated $249K.
  • Bio-Techne made up 0.03% of GAMMA Investing's portfolio in Q3 2026, its #470 holding.
  • GAMMA Investing first reported a position in Bio-Techne in Q4 2023 and has held it in 12 quarters since.
  • 15 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.